Decrease Font Size Increase Font Size Email this page to a friend Printer Friendly Page
Stemgent Reprogramming Lentiviruses

Reprogramming Lentiviruses for Human Cells

 

Stemgent Dox Lentivirus Set: hOKSM, concentrated (Product code ST000036)

Each doxycycline-inducible lentivirus in this set is capable of expressing one of four human transcription factors (Oct4, Klf4, Sox2 or c-Myc) under the control of the doxycycline (DOX)- inducible tetO operator when transduced into mammalian cells. Each unique virus is provided as a VSV-G pseudotyped virus stock capable of infecting both dividing and non-dividing cells. The expression of these four transcription factors, along with the reverse tetracycline transcriptional activator (rtTA), has been shown to reprogram human adult fibroblasts to an embryonic stem (ES) cell-like state known as the induced pluripotent stem (iPS) cell1. The DOX Inducible GFP-Lentivirus is included as a transduction control. The Stemgent Dox Lentivirus Set: hOKSM, concentrated was developed in the lab of Rudolf Jaenisch, M.D., at the Whitehead Institute at MIT1. Dr. Jaenisch is a recognized leader in the study of epigenetic regulation of gene expression with numerous publications focused on ES and iPS cellular mechanisms and techniques.

References

  1. Hockemeyer, D., Soldner, F., Cook, E.G., Gao, Q., Mitalipova, M., and Jaenisch, R. (2008) A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 3, 346-353.
  2. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
  3. Yu et al., Science 318:1917-1920 (2007).